MedPath

Shanghai Hengrui Pharmaceutical Co., Ltd.

Shanghai Hengrui Pharmaceutical Co., Ltd. logo
🇨🇳China
Ownership
Subsidiary
Established
2001-12-04
Employees
-
Market Cap
-
Website
http://www.shhrp.com

Guangshengtang's Innovative Hepatitis B Drug Included in Breakthrough Therapy List

Fujian Guangshengtang Pharmaceutical Co., Ltd. announced that its innovative hepatitis B treatment drug, Neracorvir, has been added to the Breakthrough Therapy List, potentially accelerating its development. This inclusion recognizes the drug's significant clinical advantages and novel antiviral mechanism, distinguishing it from existing treatments.
© Copyright 2025. All Rights Reserved by MedPath